Elucidating Ih Biophysical Epigenetic Modifications in VTA Dopaminergic Neurons after Contingent and Non-Contingent Cocaine Administration

NIH RePORTER · NIH · R16 · $141,272 · view on reporter.nih.gov ↗

Abstract

ABSTRACT The ventral tegmental area (VTA) is a key CNS region involved in the reward and reinforcement of natural substances and drugs, such as cocaine. Hyperpolarization-activated cation current (Ih) is a key participant in the fundamental intrinsic properties of dopaminergic (DA) neurons of the VTA. The ion channels that carry Ih are comprised of HCN subunits, predominantly the HCN2 in the VTA. Alteration of Ih due to drug exposure has been shown after cocaine sensitization (CS). This change in Ih may be a common physiological mechanism in central reward/reinforcement pathways that contributes to addiction. Epigenetic mechanisms like histone deacetylation are responsible for some crucial neuronal changes that occur following chronic drug administration. This project will study the epigenetic regulation of the Ih function during the development of CS and on the Intermittent access self-administration (IntA) model. The IntA in our opinion better simulates human drug consumption. The specific aims will include: 1) To investigate the VTA epigenomic profile after CS, IntA and Histone Deacetylase inhibitor (HDACi); 2) Electrophysiological examination of Ih in VTA DA neurons after CS, IntA and HDACi; 3) To measure changes in HCN2 subunits in the VTA after CS, IntA and HDACi; 4) To investigate if in vivo shRNA targeting HDAC2 alters the development of CS, IntA and Ih properties of VTA DA neurons. Examination of cocaine-induced epigenetic changes in the VTA can provide key information about neuroadaptations that occur during the development of addiction. The reversal of these epigenetic modifications by histone deacetylase inhibition might provide possible avenues for therapeutic pharmacological intervention.

Key facts

NIH application ID
10851998
Project number
5R16GM145475-03
Recipient
UNIVERSITY OF PUERTO RICO MED SCIENCES
Principal Investigator
CARLOS A JIMENEZ-RIVERA
Activity code
R16
Funding institute
NIH
Fiscal year
2024
Award amount
$141,272
Award type
5
Project period
2022-07-15 → 2026-06-30